Endoglin promotes endothelial cell proliferation and TGF‐β/ALK1 signal transduction

By F. Lebrin, M. Goumans, L. Jonker, Rita L. C. Carvalho, Gudrun Valdimarsdottir, M. Thorikay, C. Mummery, H. Arthur, P. ten Dijke. EMBO Journal, 2004

697 citations recorded by the source corpus.

Subfields: Cancer Research, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/adad5a373710b08ff044db390c28cf712cc2a1ba

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

1. Alicia S. Chung
2. N. Ferrara
3. John Lee
4. R. Derynck
5. Rakesh K. Jain
6. A. Adamis
7. H. Gerber

In Molecular Biology

1. Alicia S. Chung
2. Xin-Hua Feng
3. N. Ferrara
4. R. Derynck
5. John Lee
6. Rakesh K. Jain
7. Nikolaos G. Frangogiannis
8. J. Massagué

Citations in the corpus

• SPECIFICITY AND VERSATILITY IN TGF-β SIGNALING THROUGH SMADS (2005, background): “1993), endoglin is required for efficient TGF-β signaling through TβRII-ALK1 in endothelial cells (Lebrin et al. 2004).”
• Targeting the tumour vasculature: insights from physiological angiogenesis (2010, background): “Furthermore, TGFβ signalling might be modulated by the TGFβ1 type 3 receptor (also known as endoglin) that is expressed on activated endothelial cells, which enhances TGFβ1–ALK1 signalling while exerting inhibitory effects on TGFβ1–ALK5 signallin”